ArticleBMC public health2025
Unveiling China's heart disease challenges: a comprehensive retrospective study on national mortality burden.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Perioperative pulmonary infection prevention and management in adult patients after coronary artery bypass grafting: a summary of best evidence.BMC cardiovascular disorders · 2026Pooled it
- Development and validation of a clinical-ready nomogram for predicting postoperative pulmonary infection after coronary artery bypass grafting.Frontiers in cardiovascular medicine · 2026Article
- Associations between a body shape index and coronary heart disease: a case-control study in southern China.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundHeart disease has been the leading cause of death in China since 2020. With the development of the aging population, dietary habits changes, and extreme climate conditions, this study aimed to evaluate national and sub-national changes in the heart disease burden from 2013 to 2021 in china, using data from the National Mortality Surveillance System.
methodsThis study was mainly using the National Mortality Surveillance System, which covered 300 million, accounted for 24% of China's population, with national and provincial representativeness from 2013 to 2021. The data categories were modified in 2013 to contain individual classes for heart disease, and the classifications remained consist until 2021. Permutation test were used to identify the Joinpoints in the data. Trends for the study period were evaluated using the average annual percent change (AAPC) in mortality rates with 95% Confidence interval (CI). A decomposition analysis was used to analyse the drivers of mortality change due to heart disease.
resultsThe total number of heart disease related deaths increased from 277,312(2013) to 463,314(2021). The proportion of deaths due to heart disease increased from 21.81% to 25.45%. And the gender-standardized mortality of heart disease increased from 140.11/100,000 to 180.67/100,000 from 2013 to 2021. The average annual increase (AAI) was 4.46%. since 2020, the heart disease has become the leading cause of death, rising from the third place. Epidemic characteristics were as follows: First, the heart disease-related mortality was higher in males than in females. And the AAPC for males was 3.74% from 2013 to 2021 (AAPC = 3.744, 95% CI: 3.048 ~ 4.528, P < 0.01). The AAPC for females was 4.09% (AAPC = 4.088, 95% CI: 2.962 ~ 5.313, P < 0.01). Second, a rapid increase in heart disease related mortality has been observed among 15-44 years population in recent years. Third, the mortality of rural residents in the past 6 years has increased fast (from 151.19/100,000 to 188.58/100,000). The average annual increase in rural heart disease mortality was 3.49%. Fourth, heart disease mortality in Central China increased fast and reached the highest rate in China. Additionally, ischemic heart disease mortality showed the highest, with a rapidly increasing trend. Finally, most heart disease related deaths occurred from October of the first year to March of the following year, with peaks in January and February. And over 70% of these deaths occured at home or in hospital,.
conclusionsThe deaths due to heart disease indicated a remarkable continues increase in the burden of heart disease. This study results imply escalating healthcare expenses, with projections indicating even greater future challenges. These findings will also help identify gaps in heart disease healthcare and guide the prioritization of health programs dirven by the needs of China.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.